Summit Clinical Research continues strong growth, surpassing 120 sites in the Summit network, and over 60 trials. We continue our growth across multiple continents with presence in North America, Latin America, and Europe.
- 8 Countries are now part of the Summit Clinical Research network.
- The countries contain over 120 sites, adept in hepatology, obesity, and Alzheimer’s disease trials.
- Cumulatively we’ve executed trials with over 70 sponsors.
We are grateful for our clinical trial sponsors, sites, and patients for their continued trust in Summit.
Summit began in the hepatology area and established a reputation for executing high-volume trials while maintaining a keen focus on data quality. Today, our services stretch beyond hepatology:
- Hepatology trials such as MASH and MASLD continue to be a key component to our trials.
- Given the high volume of screen failures in MASH, we support obesity trials to offer patients various options.
- We’ve expanded in Alzheimer’s disease to capitalize on the overlapping procedural load.
We look forward to supporting your trials. Reach out to learn more!